Phase 3 Trial of ICLUSIG® (ponatinib) Met Primary Endpoint in Newly-Diagnosed Ph+ ALL, a Setting with No Targeted Treatments Approved in the US
- The PhALLCON Study Is the First Global, Phase 3, Registrational, and Only Head-To-Head Clinical…
- The PhALLCON Study Is the First Global, Phase 3, Registrational, and Only Head-To-Head Clinical…
DUBLIN--(BUSINESS WIRE)--The "Vietnam Ultrasound Systems Market, By Technology (Diagnostic Ultrasound v/s Therapeutic Ultrasound), By Display…
Notes That Fuji Soft is Seeking to Expand the Board and Fill Director Seats with…
- Company Announces First Half Cash Dividend of $0.10 Per Share - MACAO--(BUSINESS WIRE)--Deswell Industries,…
EL SEGUNDO, Calif.--(BUSINESS WIRE)--#USARMY--Pacific Defense, a leading open systems integrator delivering Modular Open Systems Approach…
DUBLIN--(BUSINESS WIRE)--The "Australasian Inter-Service Incident Management System (AIIMS) Tecnologies & Tools - Main Players Analysis…
— Toward achievement of sustainability — NEW YORK & DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)--#asahikasei--Asahi Kasei,…
AR/VR interactive caring and epidemic prevention are advanced smart technologies JAKARTA TIMUR, Indonesia--(BUSINESS WIRE)--ASTER_Wise Smart…
TAMPERE, Finland--(BUSINESS WIRE)--#AuroraAI--Tampere, one of Finland's largest cities, is the first in Europe to introduce…
Collaboration leverages Tenacia’s CNS, R&D, and local market expertise to support expansion of ganaxolone’s development…